Narayana Hrudayalaya Ltd

Narayana Hrudayalaya will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

Narayana Hrudayalaya UK is a wholly owned subsidiary of Cayman Islands-based Health City Cayman Islands, which is a wholly owned subsidiary of Narayana Hrudayalaya. Practice Plus Group Hospitals is an operator of hospitals in the United Kingdom. The company has 7 hospitals, 3 surgical centers, 2 urgent treatment centers, 3 musculoskeletal/diagnostic centers, 1 ophthalmology center with a total capacity of 330 beds. It had recorded turnover of GBP 250 million estimated in FY25 in the year ended September 2025. Narayana Hrudayalaya said that this acquisition will build upon the international presence of the comapny, following the successful expansion in the Caribbean through Health City Cayman Islands. The total consideration for the acquisition is GBP 188.78 million for the 100% stake, which comprises of 60,001 equity shares of face value of GBP 0.02 each of Practice Plus Group Hospitals. The per share price for the acquisition will be GBP 3146.29. The company further said that the closing date shall be within six business days after the date of the agreement or such other date as may be agreed in writing between the seller and the purchaser. Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company has a network of 18 hospitals and 2 heart centers across India along with overseas presence at Cayman Islands, with over 5,550 operational beds and a capacity of over 5,900 beds. The company had reported 2.3% fall in consolidated net profit to Rs 196.1 crore on a 15.4% increase in revenue to Rs 1,507.3 crore in Q1 FY26 as compared with Q1 FY25. The scrip shed 0.85% to currently trade at Rs 1777.70 on the BSE. Powered by Capital Market - Live

Net profit of Narayana Hrudayalaya declined 2.35% to Rs 196.65 crore in the quarter ended June 2025 as against Rs 201.38 crore during the previous quarter ended June 2024. Sales rose 15.39% to Rs 1507.27 crore in the quarter ended June 2025 as against Rs 1306.27 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1507.271306.27 15 OPM %22.3323.15 - PBDT315.14291.80 8 PBT230.83230.51 0 NP196.65201.38 -2 Powered by Capital Market - Live

Narayana Hrudayalaya will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live

Profit before tax stood at Rs 253.02 crore during the quarter, registering a growth of 13.86% from Rs 222.22 crore reported in Q4 FY24. India's revenue stood at Rs 1,108.8 crore, up 10.66% year-on-year (YoY), while revenue from the Cayman Islands was Rs 379.7 crore, up 50.2% YoY. Consolidated EBITDA grew by 22.17% to Rs 384.6 crore in the March 2025 quarter from Rs 314.8 crore in Q4 FY24. EBITDA margin improved to 26.1% in Q4 FY25 as against 25.3% in Q4 FY24. On the margins front, the company's operating margin reduced to 24.25% in Q4 FY25, compared with 23.02% recorded in Q4 FY24. Net profit margin declined to 13.30% in Q4 FY25 from 14.91% registered in Q4 FY24. As of March 31, 2025, the company's total borrowings, net of cash, bank balances, and current investments, stood at Rs 533 crore. The net debt-to-equity ratio was at 0.15, with foreign currency-denominated debt amounting to $86.8 million. On a full-year basis, the company's net profit rose 0.11% to Rs 790.16 crore on a 12.12% rise in revenue to Rs 5,482.98 crore in FY25 over FY24. Dr. Emmanuel Rupert, managing director and group CEO, Narayana Hrudayalaya, said, 'The current financial year demonstrated strong performance across our units, both domestic and international; we are pleased to report the highest-ever revenues and profitability margins on both a quarterly and an annual basis at the consolidated level. The performance improvement in India units has been driven by domestic volume pickup, increased realizations, and optimization in payor categories. While our flagships continue to contribute significantly, our Southern Peripheral and North units have shown significant growth this year, and we hope to build on the momentum going forward. The new hospital in Camana Bay is fully functional and is contributing meaningfully to the overall Cayman business. We are excited about the traction in the new hospital and are confident that the region will deliver strong growth going forward. The integrated care business is picking up well, with our new clinics garnering sizeable footfalls. We will continue to invest in this business and are optimistic that it will be a significant driver of growth for the overall NH ecosystem. We thank the investor community for their faith in us and remain confident of delivering on expectations for the upcoming year.' Meanwhile, the board has recommended a final dividend of Rs 4.50 per equity share for the financial year ended March 31, 2025. The record date for determining eligible shareholders has been set as Friday, 1 August 2025. Additionally, the board approved a proposal to seek shareholder approval via special resolution to raise up to Rs 1,500 crore in a financial year through the issuance of debt securities, including non-convertible debentures (NCDs), in one or more tranches on a private placement basis. The securities may be denominated in Indian rupees or foreign currency. Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company has a network of 18 hospitals and 2 heart centers across India, along with an overseas presence in the Cayman Islands, with over 5,550 operational beds and a capacity of over 5,900 beds.Powered by Capital Market - Live

Narayana Hrudayalaya announced that the 25th Annual General Meeting(AGM) of the company will be held on 29 August 2025.Powered by Capital Market - Live

Narayana Hrudayalaya announced that the Board of Directors of the Company at its meeting held on 23 May 2025, inter alia, have recommended the final dividend of Rs 4.5 per equity Share (i.e. 45%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Net profit of Narayana Hrudayalaya rose 3.41% to Rs 197.21 crore in the quarter ended March 2025 as against Rs 190.71 crore during the previous quarter ended March 2024. Sales rose 18.39% to Rs 1475.44 crore in the quarter ended March 2025 as against Rs 1246.25 crore during the previous quarter ended March 2024. For the full year,net profit rose 0.11% to Rs 790.16 crore in the year ended March 2025 as against Rs 789.26 crore during the previous year ended March 2024. Sales rose 12.12% to Rs 5482.98 crore in the year ended March 2025 as against Rs 4890.21 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1475.441246.25 18 5482.984890.21 12 OPM %24.2523.35 -23.2823.47 - PBDT343.88286.74 20 1222.011125.47 9 PBT261.38222.22 18 943.90883.99 7 NP197.21190.71 3 790.16789.26 0 Powered by Capital Market - Live

Narayana Hrudayalaya will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live

Kammavari Sangham will set-up hospital infrastructure with capacity of 110 beds in the Bengaluru South region. The project is expected to commence operations in the FY 2026-27. Under the terms of the agreement, Kammavari Sangham shall provide hospital facility to Narayana Hrudayalaya in the Bengaluru South region on a long-term basis. The company would run and operate the said hospital as per the terms of the agreement. Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company's consolidated net profit increased 2.6% to Rs 192.94 crore in Q3 FY25 as compared with Rs 188.02 crore in Q3 FY24. Net sales jumped 13.5% YoY to Rs 1366.68 crore during the quarter ended 31st December 2024. The scrip had gained 0.76% to end at Rs 1677.90 on the BSE on Friday. Powered by Capital Market - Live